Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,283 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07787208RecruitingPhase 1
Experimental drug for advanced solid tumors
This trial tests an investigational drug called ONO-7429 for people with advanced or recurrent solid tumors that have not responded to standard treatments. The goal is to see if the drug can help control the cancer.
Kashiwa, ChibaAges 18 years+ - NCT07789899RecruitingPhase 1
Safety study of a new investigational drug in healthy volunteers
This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.
CambridgeAges 18–55 - NCT07785934RecruitingPhase 1
Testing a new weight management injection for drug interactions
This study tests a new injectable medication for weight management in people with overweight or obesity. It investigates how the drug interacts with other medications and checks its safety. Participation requires a 6-month commitment with regular study visits.
Hefei, AnhuiAges 18–45 - NCT07784270RecruitingPhase 3
Weight loss injection for adults with type 2 diabetes and overweight
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
Fairhope, AlabamaAges 18 years+ - NCT07791043RecruitingPhase 2
Efimosfermin alfa for alcohol-related liver disease
This study tests an investigational medicine called efimosfermin alfa to see if it is safe and effective for people with liver damage caused by heavy drinking. The medicine is compared to a placebo (a dummy treatment).
Topeka, KansasAges 18–75 - NCT07784894RecruitingPhase 1
Study of an experimental drug with a birth control pill in healthy women
This trial tests how the body handles an experimental drug when taken with a combined birth control pill. It may help future use of the drug in women who are past menopause.
MadridAges 18–64 - NCT07785154Recruiting
Tracking health for people with blastic plasmacytoid dendritic cell neoplasm
This study follows people with a rare blood cancer called BPDCN who are starting or recently started a medicine called Elzonris (tagraxofusp). It collects health information to see how the treatment works over time.
InnsbruckAges 18 years+ - NCT07784725RecruitingPhase 3
Study of a weight loss injection for adults with obesity
This study tests a new medicine to help adults with obesity or overweight lose weight. It's for people who have had trouble losing weight in the past and don't have diabetes.
Dothan, AlabamaAges 18 years+ - NCT07790562RecruitingPhase 1
Study of an iron injection for people with iron deficiency anemia
This study tests an iron injection for treating iron deficiency anemia. It checks how the medicine works in the body, and may help people whose blood iron is too low.
ZhengzhouAges 18 years+ - NCT07784387Recruiting
Bladder cancer study in Portugal
This study looks at the characteristics and outcomes of people with high-risk non-muscle-invasive bladder cancer in Portugal. It aims to understand the disease better and could help improve future treatments.
LisbonAges 18 years+ - NCT07783542RecruitingPhase 2
Treatment for moderate to severe hidradenitis suppurativa
This study tests a new medication called ORKA-002 to see if it can reduce the number of painful bumps and sores in people with moderate to severe hidradenitis suppurativa (a chronic skin condition). It may be an option for people who have not had success with antibiotic treatments.
Birmingham, AlabamaAges 18–79 - NCT07776782RecruitingPhase 1
Testing a new drug with infliximab in healthy volunteers
This study tests a new experimental drug called MT-201 when given with an existing medicine (infliximab) to healthy people. It helps doctors learn how the drugs work in the body and whether they are safe.
San Diego, CaliforniaAges 19–55 - NCT07780669RecruitingPhase 3
Study of a new drug for moderate to severe COPD in smokers
This study tests a new medication (GSK5784283) for people with moderate to severe COPD who have a certain type of inflammation (eosinophilic). Participants must be on standard inhaler therapy and have a history of smoking. The trial will compare the new drug to a placebo.
Doral, FloridaAges 40–80 - NCT07782957RecruitingPhase 3
New shot for severe nasal polyps with ongoing sinus symptoms
This study tests an experimental medication called felcorekibart, given as an injection, to see if it reduces nasal polyps and improves sinus symptoms like congestion and loss of smell. It is for adults who have had nasal polyps for at least a year and have already tried standard treatments like steroid sprays or pills, or had surgery.
Sherman Oaks, CaliforniaAges 18 years+ - NCT07776509RecruitingPhase 3
Adding a new drug to current weight-loss therapy for adults with obesity or overweight
This study tests a new medication (AZD6234) added to your current weight-management medication (an incretin-based drug) to see if it helps with weight loss. You may be eligible if you are overweight or obese with related health issues or type 2 diabetes.
Escondido, CaliforniaAges 18 years+ - NCT07780643RecruitingPhase 3
Asthma study for uncontrolled asthma on inhaled steroids
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
Miami Lakes, FloridaAges 12–80 - NCT07775924RecruitingPhase 2
New drug for moderate to severe lichen planus
This study tests a new medication for people with moderate to severe lichen planus that has not improved with topical treatments. The goal is to see if it reduces symptoms and improves quality of life.
Birmingham, AlabamaAges 18–99 - NCT07779408RecruitingPhase 1/Phase 2
H5N8 flu vaccine study for healthy adults
This study tests an experimental flu vaccine designed to protect against the H5N8 bird flu virus. It is given with an ingredient that may boost the immune response. The study will check if the vaccine is safe and how well it triggers the body's defenses.
Tempe, ArizonaAges 18 years+ - NCT07779252RecruitingPhase 3
Study of a new treatment for frown lines between the eyebrows
This study tests a new medication (IPN10200) to safely reduce moderate to severe frown lines between the eyebrows in adults. It may help if you are bothered by these lines and are looking for a non-surgical option.
Guangzhou, GuangdongAges 18 years+ - NCT07782996RecruitingPhase 3
Study of a new asthma drug for people with uncontrolled asthma
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
Miami Lakes, FloridaAges 12–80 - NCT07782970RecruitingPhase 3
Treatment for chronic sinusitis with nasal polyps
This study tests a new medication (felcorekibart) to see if it reduces nasal polyps and symptoms like congestion and loss of smell. It may help people whose current treatments aren't enough.
Los Angeles, CaliforniaAges 18 years+ - NCT07780656RecruitingPhase 3
Felcorekibart for chronic obstructive pulmonary disease (COPD)
This study tests a new medicine, felcorekibart, to see if it can reduce COPD flare-ups better than a placebo after 52 weeks. It's designed for people with high eosinophils, a type of white blood cell linked to inflammation.
Miami, FloridaAges 40–80 - NCT05449119Recruiting
Study links gut health, diet, and thinking and movement in seniors
This study looks at how differences in gut bacteria and nutrition may relate to changes in thinking and movement in people over 75 who have a reduced appetite (“small eaters”). It may help doctors better understand what could be contributing to these problems and how nutrition might play a role.
DijonAges 75 years+ - NCT07778524RecruitingPhase 1
Alpelisib challenge test for body weight study
This study tests a single dose of a drug called alpelisib to see how it affects body weight and metabolism. It may help researchers understand how the drug could be used for weight-related conditions.
New York, New YorkAges 18–70
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,283 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.